Skip to main content

Brant Allen Inman, MD, MS

Cary N. Robertson, MD, Associate Professor
Associate Professor of Surgery
Office: 3007 Snyderman Bldg, 905 La Salle Street, Durham, NC 27710
Campus Mail: DUMC DUMC Box 103868, Durham, NC 27710

Clinical research interests:
Clinical trials of novel diagnostic tests and therapies for genitourinary malignancies, with a strong focus on bladder cancer.

Basic science research interests:
Immune therapies for cancer, hyperthermia and heat-based treatment of cancer, molecular biology of genitourinary cancers, novel diagnostics and therapies for genitourinary cancers

Education and Training

  • Fellowship, Urologic Oncology, Mayo Clinic, 2005 - 2008
  • Residency, Urology, Universite Laval (Canada), 2001 - 2005
  • M.S., Mayo Medical School, 2011
  • M.D., University of Alberta (Canada), 2000
  • B.S., University of Alberta (Canada), 1999


Furuya, Hideki, Charles J. Rosser, Brant A. Inman, and Joseph J. Fantony. “Reply to 'It May be Time to Abandon Urine Tests for Bladder Cancer'..” J Natl Compr Canc Netw 15, no. 5 (May 2017): lxx–lxxii.

Full Text

Brousell, Steven C., Thomas A. Longo, Joseph J. Fantony, Wiguins Etienne, David Needham, Mark W. Dewhirst, Paolo F. Maccarini, Ivan Spasojevic, and Brant A. Inman. “MP65-08 HEAT-TARGETED DRUG DELIVERY USING THE COMBAT BRS DEVICE FOR TREATING BLADDER CANCER.” In Journal of Urology, Vol. 197. Ovid Technologies (Wolters Kluwer Health), 2017.

Full Text

Brousell, Steven C., Yang Liu, Paolo F. Maccarini, Gregory M. Palmer, Wiguins Etienne, Yulin Zhao, Chen-Ting Lee, Tuan Vo-Dinh, and Brant A. Inman. “MP98-09 SYNERGISTIC IMMUNO-PHOTOTHERMAL NANOTHERAPY (SYMPHONY): A NOVEL TREATMENT FOR LOCALIZED AND METASTATIC BLADDER CANCER.” In Journal of Urology, Vol. 197. Ovid Technologies (Wolters Kluwer Health), 2017.

Full Text

Giattino, Charles M., Jacob E. Gardner, Faris M. Sbahi, Kenneth C. Roberts, Mary Cooter, Eugene Moretti, Jeffrey N. Browndyke, et al. “Intraoperative Frontal Alpha-Band Power Correlates with Preoperative Neurocognitive Function in Older Adults..” Front Syst Neurosci 11 (2017).

Full Text

Fantony, Joseph J., Thomas A. Longo, Ajay Gopalakrishna, Richmond Owusu, Raymond S. Lance, Wen-Chi Foo, Brant A. Inman, and Michael R. Abern. “Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer..” Cancer Biomark 18, no. 4 (2017): 381–87.

Full Text

Longo, Thomas, Kathleen F. McGinley, Jennifer A. Freedman, Wiguins Etienne, Yuan Wu, Alexander Sibley, Kouros Owzar, et al. “Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer..” Eur Urol 70, no. 5 (November 2016): 714–17.

Full Text

Clark, P. E., P. E. Spiess, N. Agarwal, R. Bangs, S. A. Boorjian, M. K. Buyyounouski, J. A. Efstathiou, et al. “Bladder Cancer, Version 2.2016 Featured Updates to the NCCN Guidelines.” Jnccn Journal of the National Comprehensive Cancer Network 14, no. 10 (October 1, 2016): 1213–24.


Gopalakrishna, Ajay, Thomas A. Longo, Joseph J. Fantony, Megan Van Noord, and Brant A. Inman. “Lifestyle factors and health-related quality of life in bladder cancer survivors: a systematic review..” J Cancer Surviv 10, no. 5 (October 2016): 874–82.

Full Text

Clark, Peter E., Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Jason A. Efstathiou, et al. “NCCN Guidelines Insights: Bladder Cancer, Version 2.2016..” J Natl Compr Canc Netw 14, no. 10 (October 2016): 1213–24.

Full Text